ADVERTISEMENT

Gland Pharma Q3 Results Review - Work In Progress On Multiple Issues: Motilal Oswal

Gland Pharma's Q3 FY23 performance was below our expectation, affected by lower sales across key markets.

<div class="paragraphs"><p>Injectables manufactured by Gland Pharma Ltd. (Source: Company website).</p></div>
Injectables manufactured by Gland Pharma Ltd. (Source: Company website).
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More